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ABSTRACT 
 
AIM: To evaluate the efficacy of MRCP as a diagnostic tool as compared to 
ERCP in diagnosing extra-hepatic biliary abnormalities like choledocholithiasis, 
strictures and malignancies in diagnosing other ancillary findings like biliary 
ductal dilatation and abnormalities of pancreatic duct. Histopathological 
correlation is made if available. 
 
MATERIALS AND METHODS: A prospective  study  of  50  consecutive         
patients  with  biliary obstruction  referred  for MRCP with subsequent  
assessment  by  ERCP/ histopathology were included. 
 
RESULTS: MRCP had sensitivity, specificity of  100% in IHBR strictures,  
87.5% and 100% in bile duct stones, 84.6% and 94.3% in CBD strictures, 100% 
in biliary dilatation, 100% in bile duct tumor, 100% and 97.9% in gall bladder 
stones,100% and 97.9% in pancreatic dilatation, 0% and 98% in pancreatic duct 
variant,100% and 97.9% in ampulla stones, 0%and 97.9% in ampullary strictures, 
50% and 97.9% in ampullary tumors respectively. 
 
CONCLUSION: We concluded that MRCP has high diagnostic accuracy and is 
equivalent to ERCP in diagnosing IHBR strictures and CBD tumors. In cases of 
CBD strictures and CBD stones MRCP is comparable to ERCP. In our study 
MRCP shows increased sensitivity in detecting ampullary tumors than ERCP. 
Owing to a small study population, results for other biliary pathology were 
inconclusive. 
Key words: MRCP, ERCP, Biliary obstruction 
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INTRODUCTION 
 
Obstructive jaundice is caused by biliary obstruction, which is due to 
blockage in any of the ducts that carry bile from liver to gall bladder and then to 
the small intestine. The causes of obstructive jaundice are classified as intra-
hepatic or extra hepatic. Hepatitis, cirrhosis and hepato-cellular carcinoma are the 
commonest intrahepatic causes. Extra hepatic causes are divided into intra-ductal 
and extraductal etiologies. Neoplasm, choledocholithiasis, biliary strictures and 
primary sclerosing cholangitis form the major causes of intraductal obstruction. 
Extraductal causes include compression of biliary channels by neoplasms, 
pancreatitis, and cystic duct stones (Mirzzi’s syndrome). The commonest cause 
of Obstructive jaundice is stones. 
Obstruction of the biliary tract with different benign and malignant 
processes is a common clinical problem which requires accurate localization and 
discrimination of pathology. 
Once cholestasis is detected clinically or biochemically patients are usually 
referred for USG abdomen as the primary imaging investigation. 
In the evaluation of a suspected biliary obstruction, the initial choice 
remains as Transabdominal ultrasound due to its ready availability, non-
invasiveness and inexpensiveness. 
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An excellent clue in finding biliary obstruction in ultrasound has been 
ductal dilatation. However, ultrasound cannot identify the cause and level of 
obstruction accurately. Moreover, it is an operator dependent procedure and due 
to overlying bowel gas or obesity, it can provide only suboptimal imaging of 
retroperitoneal structures. 1  
Hence arose the need for a non-invasive, radiation free, non-operator 
dependent, multiplanar imaging modality which can help not only to identify the 
obstruction but also demonstrate the nature of the pathology. Magnetic resonance 
cholangiopancreatography is one such modality which was initially introduced in 
the year 1991 and has been improved since then, to the point where it is 
considered at par with Endoscopic retrograde cholangioancreatography. 
  Endoscopic retrograde cholangiopancreatography has been considered as 
gold standard in diagnosing bile disorders, but it is invasive and requires 
endoscopic cannulation, sedation, the use of ionizing radiation. In addition, ERCP 
may be associated with significant complications such as hemorrhage, sepsis, 
pancreatitis, bile leak and mortality. 
. MRCP refers to the selective fluid sensitive magnetic resonance imaging 
(MRI) of pancreatic and biliary ducts. MRCP has the advantage of potentially 
avoiding mortality and morbidity associated with ERCP.2 Also, when 
conventional T1- and T2-weighted sequences are combined together, detection 
of extraductal disease by MRCP is possible.  
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           We, in our prospective study wish to determine the diagnostic efficacy of 
MRCP considering ERCP as the gold standard and whether the MRCP can 
replace ERCP for diagnosis, while ERCP can solely be reserved for therapeutic 
applications. 
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AIMS AND OBJECTIVES 
 
 To evaluate the efficacy of MRCP as a diagnostic  tool as compared to 
ERCP in diagnosing extra-hepatic biliary abnormalities like 
choledocholithiasis, strictures and malignancies. 
 
 To evaluate efficacy of MRCP in diagnosing ancillary findings like gall 
stone disease, biliary ductal dilatation and abnormalities of the pancreatic 
duct. 
 
 To correlate the findings with histopathology if available. 
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MATERIAL & METHODS 
 
     A prospective  study  of  50  consecutive  patients  with  biliary 
obstruction  referred  for MRCP with subsequent  assessment  by  ERCP/ 
histopathology were included. 
 
The study was conducted at MRI and ERCP units in a tertiary care center. 
MRI scanner used was, 1.5-T scanner (Magneton Avanto, Siemens, Erlangen, 
Germany) using an in-house using 16 channel body coil.  
 
STUDY DESIGN 
 
 
COMPARISON OF MRCP FINDINGS WITH ERCP
ERCP –HISTOPATHOLOGY
MRCP
BIOCHEMICAL OBSTRUCTIVE JAUNDICE
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INCLUSION CRITERIA: 
 
 All consecutive patients undergoing Magnetic resonance 
cholangiopancreatography with features of biliary obstruction & 
subsequently assessed by Endoscopic retrograde 
cholangiopancreatography / histopathology. 
 
EXCLUSION CRITERIA: 
 
 Patients having a contraindication for MRI – like cardiac 
pacemaker/cochlear implant/non MR compatible clips used on brain 
aneurysms/claustrophobia. 
 
 Patients lost to follow up. 
 
 Patients not further  assessed with ERCP/Histopathology 
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Pre-procedural preparation included six hour duration of fasting which 
helps in promoting filling of gall bladder. Usually, it takes about twenty minutes 
to complete the full examination. 
 
Following sequences were obtained- 
1. Localizer in 3 planes 
2. Axial T1 In- phase trufisp 
     3. Axial T2 HASTE fat sat 
     4. Coronal T2 HASTE fat sat 
     5. Thick Slab HASTE 
     6. 3D Volume Respiratory triggered MRCP, in two planes (coronal section in    
plane with CBD, and axial section in plane with pancreatic duct). 
 
The protocol parameters of sequences are as described in table -1.  
 
 
 
 
11 
 
 
 
Table 1. Parameters used in various sequences 
Parameters T2W 
breath 
hold 
HASTE 
3D T2W 
FSE with 
respiratory 
triggering 
T2W breath 
hold HASTE 
fat saturated 
thick slab 
T1W 
sequence 
Breath 
hold 
In phase 
TRUFI 
sequence 
with 
respiratory 
triggering 
TR/TE(ms) 2000/92 3748/702 4500/792 174/7.15 4.0/1.71 
Number of 
averages 
1 1 1 1 1 
Flip angle 180 180 180 70 70 
FOV 400x325 261x261 349x349 400x299 400x300 
Matrix size 320x260 320x320 384x384 288x216 320x240 
Slice 
thickness(mm) 
6mm 10mm 40mm 6mm 4mm 
Slice gap(mm) 7.2mm 0mm NA 40mm 0mm 
Number of 
slices 
30 19 1 20mm 30 
Acquisition 
plane 
Axial Coronal 
oblique 
coronal Axial Axial,  
coronal 
Half-Fourier 
factor 
5/8 Phase 
encoding:7
/8 
Phase 
encoding off 
Phase 
encoding 
off 
Phase 
encoding 
off 
Receiver 
bandwidth 
473 200 277 230 504 
Turbo factor 211 119 307 None None 
Oversampling None 20% Slice: 33% None None 
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An axial and coronal fat sat 2D breath-hold HASTE sequence was acquired 
covering the entire liver, up on to duodenal ampulla .This was usually performed 
using two breath-hold /respiratory triggered acquisitions. 
3D respiratory-triggered heavily T2-weighted FSE sequences are 
performed in coronal plane and also in the axial oblique plane. Respiratory 
triggering was attained by using a navigator sequence which applies a MR pre-
pulse so that respiratory motion can be monitored. The navigator was placed on 
the edge of diaphragm on the coronal localizer and sagittal localizer. Triggering 
of image acquisition was done when the diaphragm interface with the lung falls 
into a pre specified window of acceptance. In such a way the imaging slice from 
a consistent position was achieved.  
Throughout this acquisition, the patient was instructed to breathe regularly.  
This acquisition took four to six minutes to complete.  A stack of 30 contiguous 
slices with 1.5mm thickness were obtained. Owing to the heavily T2-weighted 
images, high signal intensity represents pancreatico-biliary tree with structures 
adjacent to it appears as decreased signal intensity. Strictures or small filling 
defects present in the pancreatic or biliary ducts are best appreciated in this 
sequence.   
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From this volume of data, MIP reformats were obtained. Highest signal 
intensity pixels along a ray which was perpendicular to the plane of projection is 
only displayed. In this way fluid and bile-filled structures are highlighted 
strongly. If needed MIP reformats were obtained in planes such as coronal and 
sagittal oblique. 
  Additionally high resolution radial slice acquisitions, thick slab (4 cm) fat 
saturated HASTE sequence were performed if required.  
T1 weighted in phase GRE images and TRUFI images acquired in axial 
and coronal planes. Contrast enhanced T1 W fat saturated images were acquired 
if needed. 
MRCP was performed prior to ERCP and the results were evaluated by two 
radiologists with 5yrs and 20 yrs of experience and their consensus was obtained. 
ERCP was performed by well trained and experienced endoscopist. 
Cholangiograms were obtained and compared with MRCP findings. 
Considering ERCP as gold standard the sensitivity, specificity, positive 
and negative predictive values of MRCP were evaluated. If available correlation 
with histopathology was also made. 
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  REVIEW OF LITERATURE 
 
BILIARY SYSTEM 
 
Multiple channels carry bile from the hepatic parenchyma to the 
duodenum. This constitutes the biliary tree. 
The biliary tree can be classified as intra hepatic and extra hepatic bile ducts.3 
 
INTRAHEPATIC BILE DUCTS: 
 
All these biliary canaliculi unite to form segmental bile ducts and their 
drainage occurs in the following pattern: 
The right posterior duct which courses more horizontally drains the 
segments VI and VII. The segments V and VIII drain into more vertically 
oriented right anterior duct. 
The right hepatic duct is formed by union of the right anterior and right 
posterior ducts. The left hepatic duct is formed by union of segmental bile 
ducts draining the second and fourth segments. The common bile duct is then 
formed by the combination of left hepatic and right hepatic ducts. The 
segment I Bile ducts drain in to angle of their union.4 
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The ducts of the left hepatic lobe are more anterior than those of the right 
lobe. It is important, particularly when contrast cholangiogram is performed 
because contrast may not opacify independent ducts. 
 
EXTRAHEPATIC BILIARY SYSTEM: 
 
The common bile duct is formed by the cystic duct from the gallbladder 
joining with the common hepatic duct. The initial course of the common bile duct 
courses is along the free edge of lesser omentum, from where it travels posteriorly 
and reaches the pancreas and duodenum. The ampulla of Vater is formed by 
common bile duct joining with the main pancreatic duct. The major duodenal 
papillae in D2 segment of duodenum is drained by the Ampulla of Vater.5 
 
The biliary tree anatomy is as depicted in line diagram fig (1) 
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MRCP: 
 
Magnetic resonance cholangiopancreatography is a non-invasive 
imaging technique that uses magnetic resonance imaging as a means to visualize 
the biliary duct and the pancreatic duct, without the need for contrast. This was 
introduced in 1991, and since then, the spatial resolution of this technique has 
improved considerably.  
MRCP functions with heavily T2-weighted sequences and highlights static 
fluids or fluid filled slow moving structures like the pancreatic and bile duct. The 
ducts will appear hyper intense. Coronal T2-weighted images viewed as thin 
collimation images (3-5 mm), and it is subsequently processed to obtain a MIP 
(maximum intensity projection) image which is a cholangiogram like projectional 
image. Coronal thick slab (30 to 50 mm) can also be obtained, to produce the 
same effect in a very short time (<5 seconds). Usually both these are obtained to 
achieve higher accuracy.  
Latest magnetic resonance equipment allow us to perform MRCP as fast 
as within fifteen minutes. This is because of the availability of ultra-fast 
sequences. At present, MRCP is performed widely as a modality of primary 
imaging, used in assessing conditions like obstructive jaundice and other 
pancreatico-biliary duct abnormalities that may be benign or malignant.6  
The MRCP anatomy of biliary tree is as shown in the fig (2). 
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ERCP: 
 
Endoscopic retrograde cholangiopancreatography (ERCP) is a technique 
that combines endoscopy and fluoroscopy for diagnosing and treating biliary or 
pancreatic ductal abnormalities. An endoscope with a camera and light at the end 
is inserted through the esophagus, to the stomach and to the duodenum. Contrast 
media is injected in to the biliary and pancreatic ducts which are visualized on X-
rays. ERCP additionally offers an advantage of treatment once the diagnosis is 
established. Stenting, sphincetrotomy or gall stone removal can be performed in 
the same sitting. Biopsies can also be taken for tissue diagnosis. 
 
The ERCP anatomy of the biliary tree is as shown in the Fig 3. 
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Coakley FV et al assessed the efficacy of MRCP in imaging pancreatic and 
biliary duct pathology.  The study explains the procedure of Magnetic resonance 
cholangio-pancreatography (MRCP) and its uses. He quotes that “MRCP is used 
to visualize fluid in the biliary and pancreatic ducts as high signal intensity on 
T2-weighted sequence and it is the newest modality for biliary and pancreatic 
duct imaging”.  
MRCP is already known for its usefulness in an array of pancreatic and 
biliary diseases that include various congenital variants, post-cholecystectomy 
disorders, chronic pancreatitis, neoplastic duct obstruction and 
choledocholithiasis. Despite MRCP being a technique that constantly evolves, it 
still reached a developmental stage where its usefulness has been proven 
clinically which can be compared to the clinical accuracy of other conventional 
cholangiography techniques.  
With further development, MRCP is believed to have the potential in 
replacing diagnostic ERCP as the main modality for imaging the pancreatic duct 
and biliary duct.7 
 
According to Tripathi RP et al MRCP was found to have high sensitivity 
and specificity in detecting biliary abnormalities such as  biliary dilatation, bile 
duct calculi, strictures and their anatomical variants. MRCP is a well-known non-
invasive imaging investigation in diagnosing the pancreatic and biliary duct 
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abnormalities. MRCP has now extremely improved in its diagnostic efficacy with 
its increased resolution and reliability to an extent that it can replace diagnostic 
ERCP. 
 The MRCP results were analyzed in patients with pancreatic and biliary 
ductal abnormalities, and these findings were compared with surgical findings or 
with the finding of ERCP. 
There were 150 patients who had undergone MRCP by various techniques 
were evaluated. According to the reason for referral, the patients were classified 
into 4 groups. There were 65 patients with Obstructive jaundice, 25 patients with 
acute/chronic pancreatitis, 20 patients were screened prior to laparoscopic 
cholecystectomy were 20 whereas 40 patients had failed ERCP. 
 
The results were favoring MRCP as it correctly identified the biliary 
obstruction level in 58 patients out of the total 61 patients. It was possible to 
characterize the nature of stricture whether it was benign or malignant in 30 
patients out of 32 patients. Morphology of pancreatic duct was also assessed by 
MRCP duct in 13 out of 15 patients in whom ERCP has detected ductal changes.8 
Dimitrios K Christodoulou at al opined that past fifteen years, ERCP has 
significantly emerged from entirely being a tool of diagnosis into a technique that 
is now being mainly used for therapeutic purpose.9 
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 It was first used for biliary duct disorders and then subsequently was used 
for diagnosing pancreatic disorders. CT, MRCP, MRI and endoscopic 
ultrasonography gives a diagnosis in maximum number of people with pancreatic 
diseases and also helps patients and physicians to evade complications of ERCP.  
However, pancreatic endotherapy may also be beneficial in a selected 
patients with pancreatic disorders so that they can avoid complex surgery and also 
prevents them from chronic medication use. Pancreatic cyst drainage, pancreatic 
sphincterotomy and pancreatic stenting have been proved to be some of the most 
challenging and effective endoscopic interventions. These procedures should be 
performed by well-trained and experienced therapeutic endoscopists taking 
extreme caution.  
 
Huang LY et al assessed the application of ERCP in biliary ductal and 
pancreatic diseases. He included a total number of 2075 patients who underwent 
ERCP and their results were analyzed retrospectively. He also calculated the 
complications and the therapeutic effect of ERCP. In 64 cases, diagnostic ERCP 
was performed and the procedure was successful, in the remaining 2011 cases 
therapeutic ERCP was performed, and the success rate came up to 94.6%.  
Complication rates were assessed which came up to 5.1% and the most 
common complication detected was acute pancreatitis. With these above findings, 
he came to a conclusion that ERCP can be considered as the major diagnostic and 
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therapeutic tool for biliary ductal and pancreatic disease. Therapeutic ERCP has 
advantages like it is a minimally invasive procedure, safe and acts as an effective 
treatment method for biliary-pancreatic diseases.10 
 
According to Ueno E MRCP accurately demonstrates the normal as well 
as pancreatic ductal abnormalities which also include the congenital anomalies of 
pancreatic duct and biliary tree.  
MRCP was performed in 162 patients with pancreatic abnormalities which 
includes congenital anomalies of bile duct and pancreatic duct. ERCP was 
performed in 93 patients and their results were compared. Features such as 
visualizing the pancreatic duct and its branches, stenosis, filling defects and the 
presence or absence of ductal dilatation were documented.  
They concluded by saying that when comparing MRCP with ERCP, 
MRCP overestimated the MPD stenosis, meanwhile it underestimated findings 
such as pancreatic duct filling defects in pancreatitis and dilatation of the 
branches.  
 
However, it was found that MRCP was significantly more beneficial 
compared to ERCP in the diagnosing of conditions such as mucin-producing 
tumor of the pancreas and cystic lesions. Hence MRCP was proved to accurately 
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diagnose the pancreatic duct abnormalities and also the congenital anomalies of 
the biliary tree and pancreatic duct.11 
 
Vitellas KM et al in his study proved MRCP as an equally comparable 
investigation tool in diagnosing extrahepatic bile duct abnormalities when 
compared with invasive diagnostic endoscopic retrograde cholangio-
pancreatography (ERCP).  
In MRCP, calculi appears as dark filling defects in a hyperintense fluid 
background. Due to sclerosing cholangitis, bening structures appear as multifocal 
segments of dilatation and narrowing or bile ducts of normal-caliber, which 
produces a classic beaded appearance. Features such as bile duct dilatation and 
pancreatic duct dilatation in MRCP is highly in favor of malignancy of pancreatic 
head.  
In cases of pseudocyst MRCP is considered more sensitive method than 
ERCP as only less than fifty percentage of pseudocysts get filled by the contrast 
material. In conditions such as biliary cystadenomas and cystadenocarcinomas, 
the secreted mucin produces partial obstruction of the passage and filling defects 
of contrast material in ERCP whereas MRCP significantly is more accurate in 
identifying these tumors and its extent.  
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In patients in whom biliary-enteric anastomoses is present, MRCP is 
considered to be the imaging investigation of choice in the evaluation of any 
patient with suspected pancreatico-biliary disease. Another significant MRCP’s 
use, is its capability in demonstrating the abnormal anatomy of the bile duct 
before performing cholecystectomy. MRCP has also been found to be accurate in 
identification of pancreatic divisum.12 
 
According to Albert JG et al after the introduction of endoscopic retrograde 
cholangio-pancreatography (ERCP) in the year 1970, gastroenterologists have 
acquired a vast spectrum of diagnostic and therapeutic options in the biliary 
ductal and pancreatic system. In present scenario MRCP has significantly 
replaced diagnostic ERCP and thereby it avoids complications which may occur 
in endoscopic technique.13 
 
According to Angulo P et al MRCP is performed in patients with primary 
sclerosing cholangitis and biliary abnormalities. MRCP had a singnificant role in 
diagnosis.  In this study, invasive cholangiography such as PTC or ERCP, and 
MRC were performed in 73 patients, among which there were 33 male patients, 
40 female patients. Their mean age was calculated to be 56 years. 
25 
 
 Out of the total study population of 73 patients, 42 patients had benign 
biliary disease, out of which 23 patients had primary sclerosing cholangitis; 9 
patients were diagnosed with malignant biliary disease; and the remaining 22 
patients had normal biliary ducts. MRC was obtained in 73/73 (100%), and 
invasive cholangiography (2 PTC's, 68 ERCP's) procedures in 70/73. Using 
findings of ERCP/PTC as the standard, MRC was assessed and diagnostic 
accuracy was found to be greater than 90% in the diagnosis of biliary ductal 
dilatation, bile duct stones, biliary obstruction, normal biliary tree and primary 
sclerosing cholangitis.  
Therefore he proved MRC has significant diagnostic accuracy of 90% in 
diagnosing   biliary abnormalities compared to the invasive cholangiography in 
which diagnostic accuracy came up to 97%. Thus the study concluded that MRC 
has extremely high diagnostic accuracy in diagnosing biliary abnormalities. 
Owing to the noninvasive nature of MRC, it is even more advantageous over the 
invasive cholangiography where the major intention of the procedure is to arrive 
at a diagnosis.14 
 
In the study done by Rahman R et al, of 165 patients who 
underwent MRCP prior to ERCP the sensitivity and specificity of MRCP was 
calculated and was found that MRCP did not show satisfying result when 
compared with that of ERCP in diagnosing choledocholithiasis, biliary and 
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pancreatic ductal dilatation or obstruction and periductal masses. MRCP showed 
74.6% sensitivity and 83.5% specificity in detecting choledocholithiasis, 85.4% 
sensitivity and 87.4% specificity in detecting strictures, 85.9% sensitivity and 
91.2% specificity in detecting obstruction, 92.4% sensitivity and 93.5% 
specificity in detecting ductal dilatation, and 90.8% sensitivity and 92.6% 
specificity in detecting periductal masses.  
The study shows MRCP to have increased false negative results in case of 
choledocholithiasis and strictures and increased false positive results in case of 
ductal dilatation and periductal mass when compared with ERCP. Therefore, it 
cannot be used as a substitute, thereby ERCP remains the gold standard 
investigation for better visualization of the biliary tree and pancreatic duct.15 
 
Magnetic resonance cholangiopancreatography was assessed by Liang C 
et al in patients with malignant obstructive jaundice. They proved the diagnostic 
efficacy in determining the location and extent of obstruction using MRCP was 
higher and the specificity was 82.9%. 
 
Liang C, Mao H analyzed accuracy of MRCP in diagnosing malignant 
obstructive jaundice. The diagnostic accuracy of MRCP in malignant obstruction 
came up to 82.9%. Hence MRCP was proved to have high diagnostic specificity 
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in identifying the location and also the extent of obstruction. They concluded 
saying that MRCP had significant role in diagnosing malignant obstructive 
jaundice.16 
  
Miletić D et al in their study assessed that Magnetic resonance 
cholangiopancreatography (MRCP) had extremely high sensitivity and 
specificity in demonstrating the level and identifying the presence of biliary 
duct obstruction. One major weakness of MRCP is its inability to offer 
therapeutic interventions. Other significant advantage of MR cholangiography is 
that it can also be used for detecting the resectability of a malignant neoplasm 
such as hilar cholangiocarcinoma by assessing the proximal extent of disease 
where ERCP may not be successful.17 
 
According to Soto JA et al Magnetic resonance cholangiography (MRC) is 
an efficient noninvasive diagnostic imaging modality which provides high-
quality images of the biliary ducts. Factors such as sensitivity and specificity of 
the (3D FSE) Magnetic resonance cholangiography were assessed in the 
diagnosis of biliary tract abnormalities. Forty-six patients were referred for 
elective direct cholangiography out of which 45 patients underwent endoscopic 
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retrograde cholangiopancreatography and 1patient underwent percutaneous 
transhepatic cholangiography. 
Biliary ductal abnormalities such as presence of dilatation, strictures, and 
intraductal abnormalities were assessed. MRC was evaluated comparing with 
direct cholangiography as the gold standard and the sensitivity and specificity 
images were obtained in total number of 44 patients. Sensitivity for diagnosing 
biliary ductal dilatation (n = 27), bile duct strictures (n = 10), and intraductal 
pathologies (n = 7) were calculated and it was 96.3%, 90%, and 100%. In 
addition, MRC showed 16 of 17 patients with normal bile ducts (specificity, 
94.1%). Therefore, they opined that MRC has extremely high sensitivity and 
specificity in evaluating the biliary tree. Based on this study, the efficiency of 
MRC using 3D FSE found to be sufficiently high to suggest it as a diagnostic 
imaging modality in evaluating biliary tract abnormalities.18 
 
Eva C Kaltenthaler et al evaluated Magnetic resonance 
cholangiopancreatography (MRCP) and proved it to be an effective alternative 
diagnostic tool to endoscopic retrograde cholangiopancreatography (ERCP) for 
identifying biliary obstruction.  
They reviewed 25 studies reporting several conditions, including 
malignancy (4 studies), choledocholithiasis (18studies), stricture (2 studies) and 
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dilatation (5 studies) obstruction (3 studies). Three of the 18 studies reported with 
choledocholithiasis were removed from the analysis due to inadequate data, or 
study design differences.  
The sensitivity was calculated for the 15 studies of choledocholithiasis and 
it ranged from 0.50 to 1.00 while specificity which was calculated to range from 
0.83 to 1.00. Significant heterogeneity was found across the 15 studies so the 
sensitivities and specificities and the results were summarized by a Receiver 
Operating Characteristic (ROC) curve. The sensitivity was calculated and it 
ranged from 0.81 to 0.94 and specificity ranged from 0.92 to 1.00 for 
malignancy.19 
 
Vanicek J, Kyselova H et al assessed MRCP and ERCP in diagnosis of 
choledocholithiasis. All patients underwent MRCP followed by ERCP. They 
found sensitivity, specificity and diagnostic accuracy of MRCP was lower in their 
study when compared to the ERCP (92%, 91% or 93 %). They concluded saying 
complications following ERCP is more, therefore MRCP is considered in spite of 
its lower sensitivity as the investigation of choice in the diagnosis of 
choledocholithiasis by means of noninvasive methods.20 
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According to a study done by Norero E et al MRCP has a higher accuracy 
in diagnosing choledocholithiasis. Retrospective review of patients with 
suspected choledocholithiasis were studied with MRCP and other confirmatory 
test such as ERCP, surgical common bile duct exploration or transcystic 
cholangiography. 125 patients were included in the study.  According to their 
study sensitivity was found to be 97%, specificity 74% positive predictive value 
89%, negative predictive value 90% and hence the accuracy of MRCP was 90% 
for the diagnosis of choledocholithiasis.21 
 
Miao L et al evaluated   diagnostic value of ultrasonography, MRCP and 
ERCP in common duct stones. 384 patients with suspected common duct stones 
underwent abdominal ultrasonography, MRCP and ERCP were included in the 
study. There was stone in common duct in 370 patients and no stones in 14 of 
384 patients. US detected stones in 268 cases, with 8 false positive 
results. MRCP diagnosed stones in 362 cases and false positive result in 6 cases, 
ERCP diagnosed stones in 370 cases. The diagnostic accuracy of US, MRCP and 
ERCP was 70.3% (260/370), 96.2% (356/370) and 100%.22 
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Hekimoglu K et al assessed the diagnostic efficacy of few new MR 
sequences in MRCP and its comparison with ERCP along with review of current 
literatures. A total number of two hundred and sixty nine patients were included 
in this study. Among the 269 patients, there were 25 males and 145 females, 
whose mean age ranges from 23-92. The MRCP procedure was performed before 
the ERCP in all cases. All MRCP studies were performed with new MR technique 
using a heavily T2-weighted turbo spin echo (TSE) sequence.  
The TSE sequence is one of the most widely used multiplanar 3-D MR 
technique currently, has high spatial resolution and fast imaging capacity. The 
study participants were divided into four main groups; group I consist of normal, 
group II includes stone disease, group III includes tumor and others into group 
IV. Group I comprises of 228 patients who had a normal pancreatic duct and 
biliary tree on both the investigations MRCP and ERCP.  
There were totally 18 patients in group II, for whom the MRCP sensitivity 
and specificity was calculated which came up to 88.9% and 100% for diagnosing 
biliary stone disease. It was found that the positive predictive value (PPV) was 
100%, the negative predictive value (NPV) was 99.2% and accuracy 99.2%. 
MRCP had sensitivity of 100% and specificity of 100% for the 20 patients who 
were in group III. Its PPV was 100%, NPV was 100% and accuracy was 100%.23 
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According to Halefoglu AM et al MRCP has a much lower complication 
rate when compared to ERCP. As already proved ERCP is considered as the gold 
standard investigation for biliary tract imaging but is less invasive and is also 
associated with complications.24  
 
Howard K et al assessed MRCP’s value in diagnosing biliary abnormalities 
in post cholecystectomy patients. According to their study, MRCP’s accuracy is 
comparable to ERCP. MRCP was found to be effective and also cost-effective 
when compared to ERCP, especially in patients for whom the suspected disease 
prevalence is low, thereby avoiding further intervention.  
The results of their study proved that MRCP was dominant over ERCP. 
The results showed that, there was 59% likelihood that MRCP was cost saving 
for whom there is a low to moderate probability of common bile duct stones. It 
was seen that, with a higher adjusted quality survival, there was 83% chance of 
MRCP being more effective and it also had a better cost-effectiveness ratio.25 
   
According to H Adamek et al, MRCP is as sensitive as ERCP in assessment 
biliary tract diseases. MRCP images were gathered for 60 patients. There were 
thirteen patients who had a normal bile duct. Sensitivity and specificity were 
calculated and for the detection of any abnormality it was 89% and 92%, and for 
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diagnosing malignancy it came up to 81% and 100%. These results calculated 
and were equivalent to ERCP (91% and 92% for any abnormality, and 93% and 
94% for malignant diseases).26 
         
According to Adamek HE et al, MRCP and ERCP have similar sensitivity 
in pancreatic carcinoma detection. In cases of suspected pancreatic carcinomas 
MRCP has the potential to prevent unnecessary common bile duct and pancreatic 
duct explorations, where it is highly unlikely to perform 
interventional endoscopic therapy. A total of 124 patients constituted the study.  
Of the 124 patients, pancreatic carcinomas were detected in 30% of 
patients, chronic pancreatitis was found in 46% patients, neoplastic pancreatic 
diseases were seen in 14%, clear pancreatic ducts were seen in 10% of the study 
population. In diagnosing pancreatic cancer, MRCP’s sensitivity was 84% along 
with a specificity of 97%. The sensitivity of ERCP was 70% and specificity was 
found to be 94%.27 
          
Hintze RE et al evaluated clinical importance of MRCP compared to 
ERCP. A total of 78 patients were prospectively followed up with 
ERCP and MRCP for a duration of twelve months. On a blinded basis, the images 
were interpreted by two radiologists. Features such as dilatations, intraductal 
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abnormalities and strictures were documented and clinical correlation of 
diagnosis was made. 
Among the 78 patients included in the study, images from MRCP was 
collected for 76 patients. The sensitivity of MRCP in detecting normal bile ducts 
was found to be 71%, bile duct dilatation was 83%, and stricture was 85%, correct 
stricture location in 77% and bile duct calculi was 80%. The positive predictive 
value of MRCP for normal bile ducts was 62%, bile duct dilatation was 91%, 
strictures was 100%, correct stricture location was 91% and bile duct calculi was 
100%. 
The MRCP’s sensitivity in detecting benign strictures was 50% and 
malignant strictures 80%. The sensitivity of MRCP in normal pancreatic ducts 
recognition was 33%, dilation was 62%, strictures was 76% and correct location 
was 66%, benign strictures was 87% and malignant strictures was 60% and for 
pancreatic duct stones it was 60%. The positive predictive values of MRCP 
normal pancreatic ducts recognition was 50%, dilation was 100%, strictures was 
87% and correct location was 100%, benign strictures was 87% and malignant 
strictures was 75% and for pancreatic duct stones it was 100%. Thus he concluded 
that MRCP is equivalent to ERCP in terms of contributing diagnostic information 
in many patients. Whenever inadequate results are obtained in established 
techniques, it is necessary for MRCP to be used.28 
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Siddique K et al assessed a prospective study with 60 patients. The history, 
physical examination and other investigations like ERCP, MRCP, USG abdomen, 
CT-Scan and histopathology were analyzed. Out of those 60 patients, 40 were 
male and 20 were female. Malignant obstructive jaundice was seen in 34 patients 
while 26 had benign etiology. Commonest causes for benign and malignant 
obstructive jaundice were found. Commonest malignancy was Carcinoma of the 
pancreatic head 18/60 (30%) followed by Carcinoma gall bladder 8/60 (13.33%), 
cholangiocarcinoma 7/60 (11.66%), and periampullary carcinoma 1/60 (1.66%). 
Choledocholithiasis 21/60 (35%) was the commonest benign cause followed by 
stricture of common bile duct 3/60 (5%) and acute pancreatitis 2/60 (3.33%).29 
He concluded saying obstructive jaundice is common amongst females and 
the cause is mostly malignant. Commonest malignancy was Carcinoma of the 
pancreatic head while commonest benign cause is the choledocholithiasis. 
Ultrasound, CT-Scan and ERCP are important imaging diagnostic modalities for 
evaluating patients with obstructive jaundice. ERCP has the additional 
therapeutic advantage. 
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Mosler P et al assessed the diagnostic accuracy of mangnetic resonance 
cholangiopancreaticography in identifying pancreatic divisum. ERCP is 
considered as gold standard method in the diagnosis of pancreas divisum. They 
assessed patients who had undergone both the investigations of ERCP and 
MRCP. Pancreas divisum was detected by ERCP in 19 patients out of the total 
113 patients, whereas the same was detected in 14 patients by MRCP. MRCP 
was also found to have provide three false positive results. 
Thus MRCP had 73.3% sensitivity, 96.8% specificity, and 82.4% positive 
predictive value, 94.8% was its negative predictive value. The sensitivity of 
MRCP in diagnosing pancreas divisum was around 73.3% which is 
comparatively lesser, as previous studies had reported MRCP’s sensitivity to be 
as high as 100%.30 
 
Pasanen PA et al evaluated ultrasound, ERCP and CT in assessing causes 
of benign and malignant jaundice and cholestasis. Choledocholithiasis (n = 83) 
was the most common benign disease was and carcinoma of pancreas (n = 33) 
was the most common malignant disease. The extrahepatic obstruction and its 
benign nature was correctly identified by CT, US and ERCP in 53%, 53%, and 
90% of patients, and choledocholithiasis were correctly diagnosed in22%, 25%, 
and 79%. Malignant extrahepatic obstruction was exactly diagnosed in 57%, 
80%, and 83% and in case of pancreatic cancer the values were 60%, 97%, and 
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89%. The results prove that the 3 methods of imaging are complementary to each 
other.31 
 
In the study "A prospective comparison of magnetic resonance 
cholangiopancreatography with endoscopic retrograde 
cholangiopancreatography in the evaluation of patients with suspected biliary 
tract disease "conducted by Varghese JC, Farrell MA, Courtney G et 100 patients 
underwent MRCP, in whom direct cholangiographic correlation such as ERCP, n 
= 98; PTC, n = 9; intraoperative cholangiography, n = 3 was used for comparison.  
The MRCP examinations were performed using a two-dimensional multi-
slice, fast spin echo (FSE) technique and a local surface coil. Using direct 
cholangiography choledocholithiasis was diagnosed in 30 patients, benign and 
malignant strictures diagnosed in 28 patients and normal biliary duct in 42 
patients. The benign strictures, n = 2; tumor, n = 18; lymphnode recurrence, n = 
3; unknown histology, n = 5 was evaluated by one or more of the following 
investigations: surgery (n = 8), biopsy (n = 15), cytology (n = 6) and cross-
sectional imaging/follow-up findings (n = 3). 
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This study showed MRCP diagnosed choledocholithiasis with a sensitivity 
of 93%, specificity of 99% and accuracy of 97 %. Results showed two false-
negative and one false-positive when compared with the direct cholangiography. 
Thus MRCP was found to accurately diagnose the presence and the level of 
strictures in all patients. The overall sensitivity, specificity and accuracy of 
MRCP in diagnosing biliary duct lesions were 97%, 98% and 97%. Therefore, 
according to this study MRCP has significantly high diagnostic accuracy when 
compared with direct cholangiography in the detection of bile duct disease.32 
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OBSERVATION AND RESULTS 
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RESULTS 
The results of the study are computed and tabulated below. 
I. AGE  
Table no 2 showing the age distribution of the study population. 
AGE GROUPS 
(in years) 
FREQUENCY PERCENTAGE (%) 
15 to 25 3 6 
26 to 35 5 10 
36 to 45 4 8 
46 to 55 16 32 
56 to 65 10 20 
66 to 75 5 10 
75 to 90 7 14 
  Total 50 100 
 
The above table shows that, out of the total study population, the majority 
belonged to the 46 to 55 years age group amounting to 32%. The least belonged 
to the 15 to 25 years age group with 6%. 
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Figure no 4: Age groups & Percentage. 
 
The above pie chart shows the percentage of the study population according to 
age group. 
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Figure no 5: Age groups & Frequency. 
 
Figure no 5 is a histogram showing age in groups and the number of patients in 
the study population. 
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II. SEX 
Table no 3: Gender distribution. 
SEX FREQUENCY PERCENT 
Male 28 56 
Female 22 44 
Total 50 100 
 
The above table shows that 56% of the study population were Males, and 44% 
were females. 
Figure no 6: Sex of study population. 
 
The above histogram shows the number of persons according to gender. 
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Figure no 7: Gender & percentage. 
 
 
The above pie chart shows the percentage of the study population, with 44% 
being males and 56% being females. 
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III. PATHOLOGY DETECTED IN STUDY POPULATION. 
Table no 4: Pathologies detected. 
S.NO PATHOLOGY FREQUENCY PERCENTAGE 
1 IHBR strictures 3 6 
2 Bile Duct Stones 28 56 
3 Common Bile duct Strictures 14 28 
4 Bile duct dilatation 30 60 
5 Bile duct Tumor 6 12 
6 Gall Bladder stones 4 6 
7 Pancreatic duct Dilatation 2 4 
8 Pancreatic duct variants 1 2 
9 Ampulla stones 2 4 
10 Ampulla strictures 2 4 
11 Ampulla tumor 4 8 
 
The above table shows the frequency and percentage of the various pathologies 
detected among the study population.  
The abnormalities thus detected were divided into, those involving intrahepatic 
biliary radicals, the CBD, the ampulla and of pancreatic duct. 
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Figure no 8: Frequency of pathologies detected. 
 
The above histogram shows the number of patients in which pathologies were 
detected in the study population. 
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IV. IHBR STRICTURES  
Table no 5 showing frequency and percentage of IHBR strictures 
 
The above table shows that out of the total study population, 6% had IHBR 
strictures, which were diagnosed by both ERCP and MRCP and was later 
confirmed by Histopathological examination. 
 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
No IHBR stricture 
 
47 
 
94 
 
ERCP & MRCP  
 
3 
 
6 
 
Total 
 
50 
 
100 
48 
 
 
 
 
Table no 6: Diagnostic efficacy of MRCP for IHBR strictures 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
100 
 
100 
 
100 
 
100 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
The above table shows that both MRCP and Histopathology has sensitivity and 
specificity of 100% each, whereas ERCP also had 100% sensitivity and 100% 
specificity in detecting IHBR strictures. 
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V. BILE DUCT STONES 
Table no 7: Frequency and percentage of Bile Duct Stones. 
 
 
From the above table, it is observed that MRCP detected bile duct stones in 
48% of the study population along with ERCP. ERCP alone detected bile duct 
stones in 10%.  
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
No bile duct stones 
 
21 
 
42 
 
ERCP 
 
5 
 
10 
 
ERCP & MRCP 
 
24 
 
48 
 
Total 
 
50 
 
100 
50 
 
Figure no. 9: Bile duct stones and its frequency 
 
The above histogram shows the frequency of bile duct stones detected with 
ERCP and ERCP with MRCP. 
Figure no. 10: Bile duct stones & percentage. 
 
The above pie chart shows the percentage of bile duct stones detected by ERCP 
and MRCP. 
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Table no 8:  Diagnostic efficacy of MRCP and ERCP for Bile Duct Stones 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
87.5 
 
100 
 
100 
 
84.6 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
 
In detecting Bile duct stones, it is observed that MRCP has sensitivity and 
specificity of 87.5% and 100% respectively. Sensitivity and specificity of ERCP 
is 100% each. 
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VI. COMMON BILE DUCT STRICTURES 
Table no 9: Frequency and percentage of Common bile duct Strictures  
 
ERCP detected bile duct strictures in a total of 11 patients out of which MRCP 
detected CBD strictures in 9 patients. MRCP alone detected CBD strictures in 3 
patients which were false positive. 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
No CBD strictures 
 
36 
 
72 
 
MRCP 
 
3 
 
6 
                
ERCP 
 
2 
 
4 
 
ERCP+MRCP 
 
9 
 
18 
 
Total 
 
50 
 
100 
53 
 
 
 
 
Figure no. 11: CBD strictures and percentage. 
 
The above pie chart shows the percentage of CBD strictures detected by ERCP, 
MRCP and ERCP+MRCP. ERCP alone detected 4%; MRCP detected 6% of the 
study population. ERCP+MRCP detected BCD strictures in 18% of the study 
population. 
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Table no 10: Diagnostic efficacy of MRCP, ERCP for Common bile duct 
Strictures 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
84.6 
 
92.3 
 
78.5 
 
94.7 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
In detecting common bile duct strictures, the sensitivity of MRCP was 84% and 
specificity was 92%.  
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VII. BILE DUCT DILATATION 
Table no 11: Frequency and percentage of Bile duct dilatation 
 
Above table shows that out of 50 patients ERCP and MRCP together detected 
bile duct dilatation in 30 patients. 
 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
No Bile duct dilatation 
 
20 
 
40 
 
ERCP & MRCP 
 
30 
 
60 
 
Total 
 
50 
 
100 
56 
 
 
 
 
 
Figure no. 12: Bile duct dilatation & percentage. 
 
The above pie chart describes bile duct dilation detected by ERCP+MRCP. 
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Table No 12: Diagnostic efficacy of MRCP, ERCP for Bile duct Dilatation 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
100 
 
100 
 
100 
 
100 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
In detecting bile duct dilatation, both MRCP and ERCP had 100% sensitivity 
and specificity. 
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VIII. COMMON BILE DUCT TUMOR 
Table no: 13: Frequency and percentage of Common bile duct Tumor 
 
Above table shows out of 50 patients ERCP and MRCP together detected CBD 
tumors in 6 patients.  
 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
No CBD tumors 
 
44 
 
88 
 
ERCP+MRCP 
 
6 
 
12 
 
Total 
 
50 
 
100 
59 
 
 
 
 
Table no: 14 Diagnostic efficacy of MRCP, ERCP for Common bile duct tumor 
 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
100 
 
100 
 
100 
 
100 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
The above table shows that MRCP and ERCP both had 100% efficacy in 
detecting common bile duct tumors. 
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IX. GALL BLADDER STONES 
Table no 15: Frequency and percentage of Gall Bladder stones 
 
It can be observed that gall bladder stones were detected in one patient by 
MRCP alone and in two patients by ERCP and MRCP. 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
Nil pathology 
 
47 
 
94 
 
MRCP 
 
1 
 
2 
 
ERCP+MRCP 
 
2 
 
4 
 
Total 
 
50 
 
100 
61 
 
 
 
 
Figure no. 13: Gall bladder stones and frequency 
 
Figure no 13 is a histogram showing the no of patients detected by MRCP in 
one patient and ERCP+MRCP in two other patients out of the total of 50 in the 
study population. 
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Table no 16: Diagnostic efficacy of MRCP, ERCP for Gall bladder stones 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
100 
 
97.9 
  
66.6 
 
100 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
Above table shows that sensitivity and specificity of MRCP was 100% and 
97.9%.  
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X. PANCREATIC DUCT DILATATION 
Table no 17: Frequency and percentage of Pancreatic duct Dilatation 
 
MRCP had detected pancreatic duct dilatation in one patient, whereas ERCP 
and MRCP; both were found to be positive for pancreatic ductal dilatation in 
another patient. 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
Nil pathology 
 
48 
 
96 
 
MRCP 
 
1 
 
2 
 
ERCP+MRCP 
 
1 
 
2 
 
Total 
 
50 
 
100 
64 
 
 
 
 
Table no 18: Diagnostic efficacy of MRCP, ERCP for Pancreatic duct dilatation 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
100 
 
97.9 
 
50 
 
100 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
In detecting pancreatic duct dilatation MRCP had a sensitivity and specificity of 
100% and 97.9%. ERCP had a sensitivity and specificity of 100% each. 
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XI. PANCREATIC DUCT VARIANTS 
Table no. 19: Frequency and percentage of Pancreatic duct variants 
 
Pancreatic duct variant was detected in one patient by MRCP. ERCP did not 
detect any variant of pancreatic duct. 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
Nil pathology 
 
49 
 
98 
 
MRCP 
 
1 
 
2 
 
ERCP 
 
0 
 
0 
 
Total 
 
50 
 
100 
66 
 
 
 
 
 
Table no 20: Diagnostic efficacy of MRCP, ERCP for Pancreatic duct variants 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
0 
 
98 
 
0 
 
100 
 
 Sensitivity and specificity for MRCP in detecting pancreatic duct variant was 
zero and 98% respectively. Pancreatic duct variants were not detected by ERCP 
or histopathology, making the patient detected by MRCP to be false positive. 
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XII. AMPULLA STONES 
Table no 21: Frequency and percentage of Ampulla stones 
 
The above table shows that ampulla stones were detected by MRCP in one 
patient. ERCP and MRCP both had detected ampulla stones in another patient. 
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
Nil pathology 
 
48 
 
96 
 
MRCP 
 
1 
 
2 
 
ERCP+MRCP 
 
1 
 
2 
 
Total 
 
50 
 
100 
68 
 
 
 
 
 
Table no 22: Diagnostic efficacy of MRCP, ERCP for Ampulla stones 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
100 
 
97.9 
 
50 
 
100 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
The sensitivity and specificity of MRCP in detecting ampulla stones is 100% 
and 97% respectively. ERCP had a sensitivity and specificity of 100% each. 
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XIII. AMPULLA STRICTURES 
Table no 23: Frequency and percentage of Ampulla strictures 
 
The above table shows that ampulla strictures were detected by MRCP and 
ERCP in one patient each.  
 
 
 
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
Nil pathology 
 
48 
 
96 
 
MRCP 
 
1 
 
2 
 
ERCP 
 
1 
 
2 
 
Total 
 
50 
 
100 
70 
 
 
 
 
Table no 24: Diagnostic efficacy of MRCP, ERCP for Ampulla strictures 
  
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
0 
 
97.9 
 
0 
 
97.9 
 
ERCP 
 
100 
 
100 
 
100 
 
100 
 
The sensitivity and specificity of MRCP for detecting ampulla strictures was 
zero and 97% respectively. ERCP had a sensitivity and specificity of 100% 
each. 
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XIV. AMPULLA TUMOR 
Table no 25:  Frequency and percentage of Ampulla tumor 
 
The above table shows that ampulla tumor was detected in one patient each by 
MRCP and ERCP however was not confirmed by histopathology. MRCP and 
ERCP detected in one patient each, which was confirmed to be positive by 
histopathological examination. 
   
PARAMETER 
 
FREQUENCY 
 
PERCENTAGE (%) 
 
Nil pathology 
 
46 
 
92 
 
ERCP 
 
1 
 
2 
 
MRCP 
 
1 
 
2 
 
MRCP + Histopathology 
 
1 
 
2 
 
ERCP + Histopathology 
 
1 
 
2 
 
Total 
 
50 
 
100 
72 
 
 
 
Table no 26: Diagnostic efficacy of MRCP, ERCP for Ampulla tumors 
 
PARAMETER 
 
SENSITIVITY 
(%) 
 
SPECIFICITY 
(%) 
POSITIVE 
PREDICTIVE 
VALUE (%) 
NEGATIVE 
PREDICTIVE 
VALUE (%) 
 
MRCP 
 
50 
 
97.9 
 
50 
 
97.9 
 
ERCP 
 
50 
 
97.9 
 
50 
 
97.9 
 
Histopathology 
 
100 
 
100 
 
100 
 
100 
 
The above table shows that the sensitivity and specificity of MRCP in detecting 
ampulla tumors was 50% and 97% respectively. ERCP had a sensitivity and 
specificity of 50% and 97% respectively. Histopathology is the gold standard, 
with sensitivity and specificity of 100% each. 
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XV. SUMMARY OF SENSITIVITY AND SPECIFICITY 
Table no 27:  Summary of Diagnostic efficacy for various pathologies. 
 
The above table shows sensitivity and specificity of ERCP, MRCP and 
Histopathology in detecting various pathologies. 
 
 
 
 
PARAMETER 
MRCP ERCP Histopathology 
Sensitivity 
(%) 
Specificity 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
IHBR 
Strictures 100 100 100 100 100 100 
 Bile Duct 
  Stones 87.5 100 100 100   
Strictures 84.6 92.3 100 100   
Dilatation 100 100 100 100   
Tumour 100 100 100 100 100 100 
Gall Bladder 
Stones 100 97.9 100 100   
Pancreatic Duct 
Dilatation 100 97.9 100 100   
Variants 0 98     
Ampulla 
Stones 100 97.9 100 100   
Strictures 0 97.9 100 100   
Tumour 50 97.9 50 97.9 100 100 
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Figure no. 14: Sensitivity of MRCP & ERCP 
 
 
 
The above histogram shows the sensitivity of MRCP and ERCP for various 
pathologies 
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Figure no. 15: Specificity of MRCP and ERCP 
 
The above histogram shows the specificity of MRCP and ERCP in detecting 
various pathologies shown above. 
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DISCUSSION 
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DISCUSSION 
 
The aim of our study was to assess the diagnostic efficacy of MRCP as a 
diagnostic imaging modality, compared to invasive ERCP in the diagnosis of bile 
duct abnormalities, using specificity, sensitivity and positive and negative 
predictive values. If the results favor MRCP then diagnostic ERCP could be 
completely avoided and MRCP can be used as the investigation of choice for 
diagnosing biliary abnormalities while ERCP shall be reserved only for 
therapeutic purpose solely.  
MRCP was introduced in the year 1991 as a non-invasive and a safe 
alternative to diagnostic ERCP/PTC in imaging of biliary ducts. Ever since then 
its technique has been refined, spatial resolution improved and time required 
reduced, to the point where it is considered at par with ERCP. Currently most 
centers use 3-Dimensional fat saturated heavily T2 weighted images in two planes 
and thick slab images. The use of 3D imaging has revolutionized MRC. Smallest 
of the stones (up to 4mm), and even the most subtle strictures can easily be picked 
up which were considered a limitation in thick slab images. Now as both 
sequences are routinely acquired the sensitivity and specificity of technique has 
improved. Now, the only major drawback of MRCP is lack of therapeutic option. 
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Most surgeons today would refer patients for MRCP if in doubt about the 
presence or absence of CBD stones on USG abdomen, when malignancy is a 
consideration, when ERCP is contraindicated or unsuccessful or when previous 
surgery such as biliary enteric anastamosis precludes ERCP. Though ERCP is 
considered the gold standard due to its high accuracy rate and its therapeutic value 
it can still be avoided for diagnostic purpose owing to its complications and 
operator dependency factors. MRCP has a few advantages over ERCP ; it  is 
noninvasive ,is cheaper, radiation free, requires no anesthesia, is less operator 
dependent, allows better visualization of ducts proximal to an obstruction and 
when combined with conventional T1- and T2-weighted sequences allows 
detection of extraductal disease.  
 
                Though MRCP offers many advantages it still has few drawbacks like, 
low spatial resolution, making it less sensitive to abnormalities of the peripheral 
intrahepatic ducts (eg, sclerosing cholangitis) and pancreatic ductal side branches 
(e.g. chronic pancreatitis),imaging in the physiologic, non-distended state, which 
decreases the sensitivity to subtle ductal abnormalities, image artifacts can be 
seen as bright signals arising from stationary fluid within the adjacent duodenum, 
duodenal diverticulae and ascitic fluid.33 Most important of the lot being lack of 
therapeutic option. 
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Currently, MRCP has poorer resolution than direct cholangiography and 
can miss small stones (<4 mm), small ampullary lesions, primary sclerosing 
cholangitis, and strictures of the ducts. MRCP also has difficulty in visualizing 
small stones in the pancreatic duct. Obstructing stones are generally easier to 
identify than non-obstructing stones (especially if smaller than the thickness of 
the acquired image slices). Small stones may not be distinguishable from sludge, 
mucin or even blood. Stones >4 mm are easily identified.34 
In our study group of 50 patients (28 males and 22 females), age ranging 
from 15 to 56 years, we evaluated various causes of biliary ductal obstruction. 
Commonest of the findings were choledocholithiasis (56%), malignancy (12%) 
and stricture (28%). In our study choledocholithiasis was the commonest beingn 
and ampullary malignancy to be the most common malignant cause of biliary 
obstruction which is consistent with most of the studies carried out worldwide. 
Most authors have found biliary obstruction to be commoner in women35 which 
was not the case in our study. 
     In our study the sensitivity of MRCP was found to be 87.5 % for 
choledocholithiasis, 100%for CBD malignancy, 84.6%for CBD stricture and 
100%for biliary dilatation, which was comparable to the accuracy of MRCP, 
evaluated by various authors. Overall sensitivity of various studies lies within 
74.6-90% for choledocholithiasis, 90-94% for CBD malignancy, 85-90% for 
strictures, and 90-96% for biliary dilatation. 
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In our study 3 patients had IHBR strictures on MRCP which were 
confirmed on ERCP. Thus MRCP showed 100% sensitivity and specificity in 
detecting IHBR strictures. According to C Bhatt et al36 there was no much 
difference in sensitivity and specificity of MRCP in detecting intrahepatic biliary 
strictures. Strictures were seen as narrowing of biliary radicles with upstream 
dilatation, Fig (4). The location and extent of stricture correlated with ERCP in 
all cases. 
 
About 28 of 50 patients had CBD stones. It was observed that MRCP has 
sensitivity and specificity of 87.5% and 100% respectively in detecting bile duct 
stones whereas sensitivity and specificity of ERCP was 100% considering ERCP 
is gold standard, which is consistent with the study conducted by Verma D et al 
which showed sensitivities of EUS and MRCP for the detection of 
choledocholithiasis to be 93% and 85%.37 Stones on MRCP as well as ERCP are 
seen as filling defects in lumen of CBD with or without dilatation of CBD and 
IHBR (Figure 16).The location and number of stones found on MRCP was found 
to correlate with ERCP in all cases. About 14 patients had CBD strictures, which 
were seen as narrowing of CBD with upstream dilatation (Figure17).  
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It was observed in our study that the sensitivity of MRCP was 84% and 
specificity was 92% in detecting CBD strictures Figure 18). According to the 
study conducted by Nyree Griffin et al reported sensitivity of 91-100%.38 So the 
sensitivity attained in our study was slightly lower than Nyree Griffin et al but 
comparable to other studies and fall within the overall sensitivity range of studies 
carried out worldwide. 
      In our study MRCP showed sensitivity and specificity 100 % for CBD tumors 
which was higher than the study conducted by Pamos S et al39 where the 
sensitivity and specificity was 100 and 83.3% respectively. Additionally MRCP 
was found to be better in delineating the extent of tumor and extra biliary 
extension. As other sequences could simultaneously be acquired resectability and 
nodal status could also be assessed. ERCP images showed the level of block 
however the proximal extent and involvement of adjacent structures could not be 
evaluated. 
Only four patients in our study had ampullary carcinoma with 
histopathologic confirmation (Figure 19) out of which the sensitivity and 
specificity of MRCP was around 50 % and 97.9 % for MRCP and 50% and 97.9% 
for ERCP. Of the four patients detected on ERCP and MRCP only two was 
confirmed by HPE. In one patient in whom MRCP and HPE suggested ampullary 
carcinoma, ERCP detected no ampullary carncioma thus favoring MRCP.  
82 
 
      According to the study conducted by Chen WX et al40 sensitivity and 
specificity in detection of ampullary carcinoma was 100% for ERCP and 26.83% 
for MRCP, while in our study it was 50 % and 97.9% for both. They found 
significant difference between MRCP and ERCP accuracy rate hence 
recommended ERCP in detecting ampullary carcinoma whereas our study which 
is in more in favor of MRCP. However owing to small sample result is 
inconclusive. MRCP however should score over ERCP as it offers additional 
advantage of simultaneous cross-sectional imaging. 
         About 60% patients were detected to have biliary radical dilatation on 
MRCP as well as ERCP. Thus MRCP had 100% sensitivity and specificity in 
detecting biliary duct dilatation compared to ERCP. According to Angulo et al 
diagnostic accuracy of MRCP was found to be greater than 90% in diagnosing 
biliary duct dilatation14 which is slightly lesser than the results of our study. 
 Out of 50 patients 6% had gall bladder stones in whom MRCP sensitivity 
and specificity was 100% and 97.9%. According to Calvo MM41 the sensitivity 
of MRCP in detecting cholelithiaisis was 97.7% which is comparable with the 
results of our study. On MRCP stones were seen as filling defects in gall bladder.  
 
Pancreatic dilatation was detected in two patients, the sensitivity and 
specificity of MRCP in diagnosing pancreatic duct dilatation in our study was 
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100% and 97.9%. According to Meng Z the sensitivity of MRCP in detecting 
pancreatic duct dilatation was 72.7%.42 
        
There were 2 patients who were detected to have ampullary stones and its 
sensitivity, specificity was 100% and 97.9% compared to ERCP. No major 
studies evaluating ampullary stones could be found, mostly as all cases of 
ampullary stones may be included in choledocholithiasis. However, no significant 
conclusion can be derived as the sample size is small.  
 
Ampullary stricture was found in two patients, sensitivity and specificity 
was 0% and 97.9%. The false positive rates of MRCP were high; hence ERCP 
should be considered modality of choice for ampullary stricture. 
   One out of 50 patients was diagnosed to have pancreatic divisum in MRCP 
which was not detected in ERCP therefore MRCP was to found to be false 
positive. According to Mosler et al ERCP is considered as gold standard method 
in pancreas divisum diagnosis. According to their study sensitivity of MRCP in 
diagnosing pancreas divisum was around 73.3%.30 Thus results in our study were 
in conclusive as study sample size was small. 
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Thus to conclude, MRCP has high sensitivity for CBD and intra-hepatic 
biliary radical abnormalities such as stones, strictures and malignancies. MRCP 
may have slightly lower sensitivity for stone detection, but still to avoid 
unnecessary diagnostic ERCP; in cases with suspicion (clinical/CBD -IHBR 
dilatation on USG) of choledocholithiasis/ampullary stones, MRCP is 
recommended. 
 
MRCP has comparable sensitivity for malignancies and offers additional 
advantage of cross-sectional imaging, hence should score over ERCP. Sensitivity 
of MRCP for anicillary findings like gall stones and intraheaptic biliary radical 
dilatation is comparable to ERCP. While for lower biliary system abnormalities 
like ampullary stricture and pancreatic duct abnormalities; ERCP may be 
preferred. For ampullary stones though, MRCP shows equivalent sensitivity but 
marginally low specificity as compared to ERCP. In one of the cases of ampullary 
carcinoma MRCP was positive while ERCP was not, which is likely to be an 
isolated case, considering the fact that other studies have shown considerably 
high sensititvity of  ERCP compared to MRCP, for ampullary tumor detection. 
However the sample size is a limiting factor for any definitive conclusion.  
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SUMMARY 
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SUMMARY 
This was our prospective study of 50 patients the various common causes 
of obstructive jaundice were assessed with MRCP and the diagnostic efficacy of 
MRCP was evaluated comparing with ERCP and histopathology if available.         
Of the 50 patients 6% had IHBR strictures, 56% had CBD stones, 28% had 
CBD strictures, 12% had CBD tumors, 4% had ampullary stones, 4% had 
ampullary strictures and 8% had ampullary tumor.  
In our study 3 patients had IHBR strictures where MRCP showed 100% 
sensitivity and specificity in detecting IHBR strictures. Of the 50 patients 28 had 
CBD stones, it is observed that MRCP has sensitivity and specificity of 87.5% 
and 100% respectively in detecting Bile duct stones, whereas sensitivity and 
specificity of ERCP was 100% each. 
In our study 6 had CBD tumors out of 50 patients in which the sensitivity 
and specificity ranges between 100 % and 92.3%. Only four patients in our study 
had ampullary carcinoma out of which the sensitivity and specificity came around 
66.6% and 100 % for MRCP and 33.3% and 97.9% for ERCP.  One patient, in 
whom MRCP and HPE detected ampullary carcinoma, ERCP detected no 
ampullary carncioma thus favoring MRCP.  
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However owing to inadequate study population results are inconclusive.  
There is significant difference between MRCP and ERCP accuracy rate in 
detection of ampullary carcinoma. Therefore their study recommends ERCP in 
detecting ampullary carcinoma whereas our study which is more in favor of 
MRCP.   
There were 60% patients who were detected with biliary duct dilatation in 
ERCP which was equally detected in MRCP. Thus MRCP had 100% sensitivity 
and specificity in detecting biliary duct dilatation compared to ERCP. 
Out of 50 patients 6% had gall bladder stones in whom MRCP sensitivity 
and specificity detecting gall bladder stones came up to 100% and 97.9% and was 
found to comparable with ERCP. 
One patient out of 50 patients was diagnosed to have pancreatic divisum in 
MRCP which was not detected in ERCP therefore MRCP was to found to be false 
positive. Pancreatic dilatation was detected in two patients and there were 2 
patients who were detected with ampullary stones and its sensitivity, specificity 
came up to 100% and 97.9% compared to ERCP. Another two patients who were 
found to have ampullary strictures whose sensitivity and specificity in MRCP was 
calculated and came up to 0% and 97.9%.  Owing to inadequate study population 
in above mentioned pathologies the results were inconclusive. 
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CONCLUSION 
 
The aim of our study was to evaluate the diagnostic efficacy of MRCP 
compared to ERCP as a diagnostic our institution, using specificity, sensitivity, 
and positive and negative predictive values.  
 
 We conclude that MRCP has high diagnostic accuracy and is 
equivalent to ERCP in diagnosing (IHBR and CBD) abnormalities 
like IHBR strictures and CBD tumors.  
 
 In cases of CBD strictures, CBD stones and ampullary stones, 
MRCP is comparable to ERCP.  
 
 For ampullary tumors sensitivity of MRCP and ERCP was 
equivalent, which may be fallacious considering the small sample 
size. 
 
 For lower biliary tract abnormalitites like ampullary stricture and 
pancreatic ductal abnormalitites MRCP was found to have lower 
sensitivity. 
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 Ancillary findings like intrahepatic biliary radical dilatation and gall 
stone disease are well demonstrated on MRCP. 
 
 MRCP as the method of choice for the diagnostic imaging of biliary 
and ERCP is reserved for therapeutic intervention in this setting as 
the commoner pathologies (stones ,strictures and malignancies in 
upper biliary tract) can be easily identified with high specificity with 
MRCP. 
 
 In cases wherein histopathology were available, that is in cases of 
tumors, MRCP showed high specificity as well as sensitivity. 
 
 The results obtained in the study were comparable to pioneer studies 
conducted worldwide. However major limitation was small sample 
size. 
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LIMITATIONS AND 
RECOMMENDATIONS 
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LIMITATIONS 
 
 Small  study  population, owing  to difficulty in collecting patients who 
underwent both ERCP and MRCP, as most of the patients after 
ultrasound are directly subjected to ERCP. 
 
RECOMMENDATIONS 
 
 We would propose that all cases of obstructive jaundice should undergo 
MRCP so that ERCP can be used only for therapeutic purpose. 
 
 MRCP should be performed in cases of CBD / pancreatic duct dilatation 
(when the clinical data and USG abdomen are inconclusive) to RULE OUT 
presence of stones, strictures and malignancies to avoid complications of 
diagnostic ERCP. 
 
 MRCP should be performed in cases of suspected malignancies in hilar 
region, CBD and ampulla as it provides ancillary information as discussed. 
 
 MRCP is first hand tool for diagnosing biliary abnormalities. 
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IMAGES 
 
 
 
FIG.13 PANCREATICO-BILIARY SYSTEM 
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 Fig.14 The MRCP anatomy of biliary tree is as shown in the image 
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Fig .15 ERCP 
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Figure: 15 ERCP 
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Figure:19  CBD stones is seen as filling defects in ERCP and MRCP
 
Figure: 16 CBD stones is seen as filling defects in ERCP and MRCP 
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Figure:19  CBD stones is seen as filling defects in ERCP and 
MRCP
 
Figure: 17. CBD stones is seen as filling defects in ERCP and MRCP 
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Figure20:CBD stricrtures seen as narrowing of the duct in ERCP and MRCP 
 
Figure: 18. CBD strictures seen as narrowing of the duct in ERCP and MRCP 
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Figure: 19. Thick slab image showing CBD stricture 
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Figure20:CBD stricrtures seen as narrowing of the duct in ERCP and MRCPFigure: 20. CBD strictures seen as narrowing of the duct in E P and RCP 
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Figure no:21 CBD TUMOR : Moderate dilatation of the intrahepatic biliary channels.
There is abrupt cut of off the biliary channels at the site of the 
formation of the common hepatic duct. The confluence of the right anterior
sectoral duct could not be visualized. Post contrast shows mild poorly defined 
enhancement at the confluence. 
Figure: 21. CBD tumor: Moderate dilatation of the intrahepatic biliary channels. 
There is abrupt cut of off the biliary channels at the site of the confluence of the 
common hepatic duct. The confluence of the right anterior spectral duct could 
not be visualized. Post contrast shows mild poorly defined enhancement of the 
confluence. 
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Figure: 22.  Thick slab image showing: Moderate dilatation of the intrahepatic 
biliary channels. There is abrupt cut of off the biliary channels at the site of the 
formation of the common hepatic duct.  
 
 
104 
 
 
 
 
 
Figure: 23. ERCP showing features of CBD tumor 
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Figure:22 Mass lesion in the region of ampulla with upstream 
dilatation of CBD.Figure: 24. Mass lesion in the region of ampulla with upstream dilatation of 
CBD 
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Figure:22 Mass lesion in the region of ampulla with upstream dilatation of CBD
in the region of ampulla with upstream dilatation of CBD
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Figure 22 Thick slab image showing upstream dilatation of CBD and 
dilatation of pancreatic duct in ampullary carcinoma 
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Figure: 25.  Space sequence showing ampullary mass lesion causing upstream 
dilatation of CBD. 
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Figure:22 Mass lesion in the region of ampulla with upstream dilatation of CBDFigure: 26. Mass lesion in the region of ampulla with upstream dilatation of 
CBD. 
 
 
 
 
 
110 
 
Figure:22 shows features of ampullary tumor in ERCP with 
upstream dilatation of CBD
 
Figure: 27. Shows features of ampullary tumor in ERCP with upstream 
dilatation of CBD 
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ANNEXURE I 
 
LIST OF TABLES: 
Table 1. Parameters used in various sequences 
Table no 2: Age (in groups) of the study population. 
Table no 3: Gender distribution. 
Table no 4: Pathologies detected. 
Table no 5: Frequency and percentage of IHBR strictures 
Table no 6: Diagnostic efficacy of MRCP and Histopathology for IHBR 
strictures 
Table no 7: Frequency and percentage of Bile Duct Stones. 
Table no 8:  Diagnostic efficacy of MRCP and ERCP for Bile Duct Stones 
Table no 9: Frequency and percentage of Common bile duct Strictures 
Table no 10: Diagnostic efficacy of MRCP, ERCP for Common bile duct 
Strictures 
Table no 11: Frequency and percentage of Bile duct dilatation 
Table No 12: Diagnostic efficacy of MRCP, ERCP for Bile duct Dilatation 
Table no: 13: Frequency and percentage of Common bile duct Tumor 
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Table no 14: Diagnostic efficacy of MRCP, ERCP for Common bile duct 
Tumor 
Table no 15: Frequency and percentage of Gall Bladder stones 
Table no 16: Diagnostic efficacy of MRCP, ERCP for Gall bladder stones 
Table no 17: Frequency and percentage of Pancreatic duct Dilatation 
Table no 18: Diagnostic efficacy of MRCP, ERCP for Pancreatic duct dilatation 
Table no. 19: Frequency and percentage of Pancreatic duct variants 
Table no 20: Diagnostic efficacy of MRCP, ERCP for Pancreatic duct variants 
Table no 21: Frequency and percentage of Ampulla stones 
Table no 22: Diagnostic efficacy of MRCP, ERCP for Ampulla stones 
Table no 23: Frequency and percentage of Ampulla strictures 
Table no 24: Diagnostic efficacy of MRCP, ERCP for Ampulla strictures  
Table no 25: Frequency and percentage of Ampulla tumor 
Table no 26:  Diagnostic efficacy of MRCP, ERCP and Histopathology for      
Ampulla tumors 
Table no 27:  Summary of Diagnostic efficacy of MRCP for various 
pathologies. 
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ANNEXURE II 
LIST OF FIGURES: 
Figure no 1: Age groups & Percentage. 
Figure no 2: Age groups & Frequency. 
Figure no 3: Sex of study population. 
Figure no 4: Gender & percentage. 
Figure no 5: Frequency of pathologies detected. 
Figure no. 6: Bile duct stones and frequency 
Figure no. 7: Bile duct stones & percentage. 
Figure no. 8: CBD strictures and percentage. 
Figure no. 9: Bile duct dilatation & percentage. 
Figure no. 10: Gall bladder stones and frequency 
Figure no. 11: Sensitivity of MRCP & ERCP 
Figure no. 12: Specificity of MRCP and ERCP 
Figure no. 13: Pancreatico-biliary system 
Figure no. 14: The MRCP anatomy of biliary tree is as shown in the image 
 Figure no. 15: ERCP 
Figure no. 16: CBD stones is seen as filling defects in ERCP and MRCP 
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Figure no. 17: CBD stones is seen as filling defects in ERCP and MRCP 
Figure no. 18: CBD strictures seen as narrowing of the duct in ERCP and 
MRCP 
Figure no. 19: Thick slab image showing CBD stricture 
Figure no. 20: CBD strictures seen as narrowing of the duct in ERCP and 
MRCP 
Figure no. 21: CBD tumor: Moderate dilatation of the intrahepatic biliary 
channels. 
Figure no. 22: Thick slab image showing: Moderate dilatation of the 
intrahepatic biliary channels. 
Figure no. 23: ERCP showing features of CBD tumor 
Figure no. 24: Mass lesion in region of ampulla with upstream dilatation of 
CBD 
Figure no. 25: Space sequence showing ampullary mass lesion causing 
upstream dilatation of CBD 
Figure no. 26: Mass lesion in the region of ampulla with upstream dilatation of 
CBD. 
Figure no. 27: Features of ampullary tumor in ERCP with upstream dilatation of 
CBD 
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ANNEXURE III 
 
LIST OF ABBREVIATIONS: 
CBD: Comon bile duct 
CT: Computed tomography 
ERCP: Endoscopic retrograde cholangiopancreatography 
FOV: Field of view 
FSE: Fast spin echo 
HASTE: Half-Fourier acquisition single-shot turbo spin-echo 
IHBR: Intra Hepatic Biliary Radicles 
MIP: Maximum intensity projection 
MPD: Main pancreatic duct 
MR pulse: Magnetic resonance pulse 
MRCP: Magnetic Resonance Cholangiopancreatography 
MRI: Magnetic resonance imaging 
NPV: Negative predictive value 
PPV: Positive predictive value 
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PTC: Percutaneous transhepatic cholangiography 
ROC: Receiver operations curve 
TE: Echo time 
TR: Repetition time 
true FISP: Fast imaging with steady state free precession 
TRUFI: True fast imaging with steady state free precession 
TSE: Turbo spin echo 
US: Ultrasound 
USG: Ultrasonography 
 
 
 
 
 
 
 
 
127 
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
 
128 
 
 
MASTER CHART 
 
 
 
129 
 
 
 
 
 
 
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
131 
 
PLAGIARISM REPORT FROM TURNITIN.COM 
                
132 
 
             
133 
 
 
 
 
 
 
134 
 
 
 
 
 
